Abstract
Angiogenesis, tumor cell proliferation, and migration are the hallmarks of solid tumors, such as gliomas. This study demonstrates that a fragment derived from the autocatalytic digestion of matrix metalloproteinase (MMP)-2, called PEX, acts simultaneously as an inhibitor of glioma angiogenesis, cell proliferation, and migration. PEX is detected in the cultured medium of various human glioma, endothelial, breast, and prostate carcinoma cell lines. PEX is purified from the medium of glioma cell lines by chromatography, where PEX is constitutively expressed as a free and a TIMP-2-bound form. In human glioma tissue, PEX expression correlates with histological subtype and grade and with αvβ3 integrin expression to which it is bound. Systemic administration of PEX to s.c. and intracranial human glioma xenografts results in a 99% suppression of tumor growth with no signs of toxicity. Thus, PEX is a very promising candidate for the treatment of human malignant gliomas.
| Original language | English |
|---|---|
| Pages (from-to) | 8730-8736 |
| Number of pages | 7 |
| Journal | Cancer Research |
| Volume | 61 |
| Issue number | 24 |
| Publication status | Published - Dec 15 2001 |
Fingerprint
ASJC Scopus subject areas
- Cancer Research
- Oncology
Cite this
Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2. / Bello, L.; Lucini, V.; Carrabba, G.; Giussani, C.; Machluf, M.; Pluderi, M.; Nikas, D.; Zhang, J.; Tomei, G.; Villani, R. M.; Carroll, R. S.; Bikfalvi, A.; Black, P. M.
In: Cancer Research, Vol. 61, No. 24, 15.12.2001, p. 8730-8736.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2
AU - Bello, L.
AU - Lucini, V.
AU - Carrabba, G.
AU - Giussani, C.
AU - Machluf, M.
AU - Pluderi, M.
AU - Nikas, D.
AU - Zhang, J.
AU - Tomei, G.
AU - Villani, R. M.
AU - Carroll, R. S.
AU - Bikfalvi, A.
AU - Black, P. M.
PY - 2001/12/15
Y1 - 2001/12/15
N2 - Angiogenesis, tumor cell proliferation, and migration are the hallmarks of solid tumors, such as gliomas. This study demonstrates that a fragment derived from the autocatalytic digestion of matrix metalloproteinase (MMP)-2, called PEX, acts simultaneously as an inhibitor of glioma angiogenesis, cell proliferation, and migration. PEX is detected in the cultured medium of various human glioma, endothelial, breast, and prostate carcinoma cell lines. PEX is purified from the medium of glioma cell lines by chromatography, where PEX is constitutively expressed as a free and a TIMP-2-bound form. In human glioma tissue, PEX expression correlates with histological subtype and grade and with αvβ3 integrin expression to which it is bound. Systemic administration of PEX to s.c. and intracranial human glioma xenografts results in a 99% suppression of tumor growth with no signs of toxicity. Thus, PEX is a very promising candidate for the treatment of human malignant gliomas.
AB - Angiogenesis, tumor cell proliferation, and migration are the hallmarks of solid tumors, such as gliomas. This study demonstrates that a fragment derived from the autocatalytic digestion of matrix metalloproteinase (MMP)-2, called PEX, acts simultaneously as an inhibitor of glioma angiogenesis, cell proliferation, and migration. PEX is detected in the cultured medium of various human glioma, endothelial, breast, and prostate carcinoma cell lines. PEX is purified from the medium of glioma cell lines by chromatography, where PEX is constitutively expressed as a free and a TIMP-2-bound form. In human glioma tissue, PEX expression correlates with histological subtype and grade and with αvβ3 integrin expression to which it is bound. Systemic administration of PEX to s.c. and intracranial human glioma xenografts results in a 99% suppression of tumor growth with no signs of toxicity. Thus, PEX is a very promising candidate for the treatment of human malignant gliomas.
UR - http://www.scopus.com/inward/record.url?scp=0035893737&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035893737&partnerID=8YFLogxK
M3 - Article
VL - 61
SP - 8730
EP - 8736
JO - Journal of Cancer Research
JF - Journal of Cancer Research
SN - 0008-5472
IS - 24
ER -